Kameel Garas, MD
Pain Medicine · Burlington, MANPI 1700843901
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,097 of the $5,266 with a category attached, or 77.8%. 9 manufacturers reported payments, led by Medtronic at 45.8% of the total.
Across 48 payments — averaging $109.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$869
- Abbott$784
- Relievant Medsystems, Inc.$306
- Hydrocision, Inc.$300
- Nevro Corp.$181
- plus $416 from 3 others
What the payments were for
- Consulting fees$3006%
- Travel & lodging$87017%
- Food & beverage$4,09778%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 24 | $2,411 |
| Boston Scientific | 7 | $869 |
| Abbott | 9 | $784 |
| Relievant Medsystems, Inc. | 2 | $306 |
| Hydrocision, Inc. | 1 | $300 |
| Nevro Corp. | 1 | $181 |
| SPR Therapeutics, Inc | 2 | $174 |
| Vertos Medical, Inc. | 1 | $159 |
| Fidia Pharma USA Inc. | 1 | $83 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,224
- INTELLIS$785
- SYNCHROMEDII$720
- TenJet$300
- PROCLAIM$298
- GENERAL PAIN MANAGEMENT$273
- Senza Spinal Cord Stimulation System$181
- ETERNA$178
- WaveWriter Alpha Prime 16$167
- INTELLIS ADAPTIVESTIM$162
- mild Device Kit$159
- SYNCHROMED$125
- Vanta$118
- SPRINT PNS System$116
How this compares
$5,266 in reported general payments places this provider in the 75th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 41 | $45,007 |
| Nucynta ErTapentadol Hcl | 29 | $37,688 |
| Buprenorphine | 122 | $27,189 |
| ButransBuprenorphine | 32 | $16,340 |
| Pregabalin | 332 | $6,843 |
| Lidocaine | 64 | $5,559 |
| Gabapentin | 385 | $4,532 |
| Celecoxib | 122 | $3,025 |
| Tramadol Hcl | 488 | $2,986 |
| Duloxetine Hcl | 108 | $1,988 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $729 |
| Cyclobenzaprine Hcl | 69 | $453 |
| Diclofenac Sodium | 17 | $435 |
| Tizanidine Hcl | 35 | $313 |
| Amitriptyline Hcl | 18 | $288 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Burlington
- Ali EbrahimiBurlington$41K
- Olusola AkenroyeBurlington$4K
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.